Curitex Medical Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
as on 16-11-2024
- Paid Up Capital ₹ 1.62 M
as on 16-11-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.60 Cr
as on 16-11-2024
- Revenue 126.63%
(FY 2023)
- Profit -15.48%
(FY 2023)
- Ebitda -25.40%
(FY 2023)
- Net Worth 9.31%
(FY 2023)
- Total Assets 3.55%
(FY 2023)
About Curitex Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 1.62 M.
The company currently has active open charges totaling ₹2.60 Cr.
Abhay Poundarik, Anjali Poundarik, and Atharva Poundarik serve as directors at the Company.
- CIN/LLPIN
U33300GJ2017PTC095987
- Company No.
095987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Curitex Medical Private Limited offer?
Curitex Medical Private Limited offers a wide range of products and services, including Yarns & Threads, Cotton, Bandages & Dressing Disposables, Cotton Rolls, Surgical Cotton.
Who are the key members and board of directors at Curitex Medical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Poundarik  | Managing Director | 27-Feb-2017 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Atharva Poundarik | Director | 27-Feb-2017 | Current |
| Anjali Poundarik | Director | 27-Feb-2017 | Current |
Financial Performance of Curitex Medical.
Curitex Medical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 126.63% increase. The company also saw a substantial fall in profitability, with a 15.48% decrease in profit. The company's net worth moved up by a moderate rise of 9.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curitex Medical?
In 2023, Curitex Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Iit Ropar-Technology Business Incubator FoundationActive 8 years 8 monthsAtharva Poundarik is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Jun 2018 | ₹1.30 Cr | Open |
Others Creation Date: 07 Jun 2018 | ₹1.50 M | Open |
Others Creation Date: 07 Jun 2018 | ₹1.15 Cr | Open |
How Many Employees Work at Curitex Medical?
Unlock and access historical data on people associated with Curitex Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curitex Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curitex Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.